Qiagen N.V. (QGEN) SEC Filing 6-K Foreign Issuer Report for the period ending Wednesday, June 30, 2021

Qiagen Nv

CIK: 1015820 Ticker: QGEN

View differences made from one to another to evaluate Qiagen Nv's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Qiagen Nv.


Assess how Qiagen Nv's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Qiagen Nv's Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


Ticker: QGEN
CIK: 1015820
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001015820-21-000043
Submitted to the SEC: Fri Jul 30 2021 6:57:34 PM EST
Accepted by the SEC: Mon Aug 02 2021
Period: Wednesday, June 30, 2021
Industry: Biological Products No Disgnostic Substances

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: